As of 2024-12-15, the Intrinsic Value of XORTX Therapeutics Inc (XRX.CN) is
- CAD. This XRX.CN valuation is based on the model Peter Lynch Fair Value.
With the current market price of 1.90 CAD, the upside of XORTX Therapeutics Inc is
-100.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
XRX.CN Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
- - - |
- |
-100.00% |
| P/E |
(0.03) - (2.41) |
(0.03) |
-101.8% |
| DDM - Stable |
(2.28) - (6.10) |
(4.19) |
-320.6% |
| DDM - Multi |
(0.79) - (1.67) |
(1.08) |
-156.7% |
XRX.CN Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
18.48 |
| Beta |
0.10 |
| Outstanding shares (mil) |
9.73 |
| Enterprise Value (mil) |
13.34 |
| Market risk premium |
4.74% |
| Cost of Equity |
11.63% |
| Cost of Debt |
5.00% |
| WACC |
7.65% |